Cue Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.About CUE
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology).
CEOUsman Azam
CEOUsman Azam
Employees41
Employees41
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2014
Founded2014
Employees41
Employees41
CUE Key Statistics
Market cap44.18M
Market cap44.18M
Price-Earnings ratio-1.23
Price-Earnings ratio-1.23
Dividend yield—
Dividend yield—
Average volume174.48K
Average volume174.48K
High today$0.5898
High today$0.5898
Low today$0.555
Low today$0.555
Open price$0.5611
Open price$0.5611
Volume160.23K
Volume160.23K
52 Week high$1.75
52 Week high$1.75
52 Week low$0.54
52 Week low$0.54
Stock Snapshot
Cue Biopharma(CUE) stock is priced at $0.56, giving the company a market capitalization of 44.18M. It carries a P/E multiple of -1.23.
As of 2025-12-04, Cue Biopharma(CUE) stock has fluctuated between $0.56 and $0.59. The current price stands at $0.56, placing the stock +0.9% above today's low and -5.1% off the high.
Cue Biopharma(CUE) shares are trading with a volume of 160.23K, against a daily average of 174.48K.
During the past year, Cue Biopharma(CUE) stock moved between $0.54 at its lowest and $1.75 at its peak.
During the past year, Cue Biopharma(CUE) stock moved between $0.54 at its lowest and $1.75 at its peak.
People also own
Based on the portfolios of people who own CUE. This list is generated using Robinhood data, and it’s not a recommendation.